50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,636.45 (-2.22%)
DOW   29,176.82 (-1.71%)
QQQ   270.75 (-3.28%)
AAPL   142.20 (-5.10%)
MSFT   235.37 (-2.36%)
META   137.26 (-3.07%)
GOOGL   96.43 (-3.62%)
AMZN   114.28 (-3.16%)
TSLA   267.87 (-6.93%)
NVDA   120.93 (-5.05%)
NIO   15.59 (-10.04%)
BABA   78.52 (-3.05%)
AMD   63.92 (-6.50%)
T   15.52 (-1.96%)
MU   49.86 (-2.24%)
CGC   2.82 (-7.24%)
F   11.44 (-6.08%)
GE   62.26 (-3.41%)
DIS   96.98 (-2.43%)
AMC   7.11 (-7.30%)
PYPL   88.87 (-2.47%)
PFE   44.18 (-0.56%)
NFLX   239.19 (-2.45%)
S&P 500   3,636.45 (-2.22%)
DOW   29,176.82 (-1.71%)
QQQ   270.75 (-3.28%)
AAPL   142.20 (-5.10%)
MSFT   235.37 (-2.36%)
META   137.26 (-3.07%)
GOOGL   96.43 (-3.62%)
AMZN   114.28 (-3.16%)
TSLA   267.87 (-6.93%)
NVDA   120.93 (-5.05%)
NIO   15.59 (-10.04%)
BABA   78.52 (-3.05%)
AMD   63.92 (-6.50%)
T   15.52 (-1.96%)
MU   49.86 (-2.24%)
CGC   2.82 (-7.24%)
F   11.44 (-6.08%)
GE   62.26 (-3.41%)
DIS   96.98 (-2.43%)
AMC   7.11 (-7.30%)
PYPL   88.87 (-2.47%)
PFE   44.18 (-0.56%)
NFLX   239.19 (-2.45%)
S&P 500   3,636.45 (-2.22%)
DOW   29,176.82 (-1.71%)
QQQ   270.75 (-3.28%)
AAPL   142.20 (-5.10%)
MSFT   235.37 (-2.36%)
META   137.26 (-3.07%)
GOOGL   96.43 (-3.62%)
AMZN   114.28 (-3.16%)
TSLA   267.87 (-6.93%)
NVDA   120.93 (-5.05%)
NIO   15.59 (-10.04%)
BABA   78.52 (-3.05%)
AMD   63.92 (-6.50%)
T   15.52 (-1.96%)
MU   49.86 (-2.24%)
CGC   2.82 (-7.24%)
F   11.44 (-6.08%)
GE   62.26 (-3.41%)
DIS   96.98 (-2.43%)
AMC   7.11 (-7.30%)
PYPL   88.87 (-2.47%)
PFE   44.18 (-0.56%)
NFLX   239.19 (-2.45%)
S&P 500   3,636.45 (-2.22%)
DOW   29,176.82 (-1.71%)
QQQ   270.75 (-3.28%)
AAPL   142.20 (-5.10%)
MSFT   235.37 (-2.36%)
META   137.26 (-3.07%)
GOOGL   96.43 (-3.62%)
AMZN   114.28 (-3.16%)
TSLA   267.87 (-6.93%)
NVDA   120.93 (-5.05%)
NIO   15.59 (-10.04%)
BABA   78.52 (-3.05%)
AMD   63.92 (-6.50%)
T   15.52 (-1.96%)
MU   49.86 (-2.24%)
CGC   2.82 (-7.24%)
F   11.44 (-6.08%)
GE   62.26 (-3.41%)
DIS   96.98 (-2.43%)
AMC   7.11 (-7.30%)
PYPL   88.87 (-2.47%)
PFE   44.18 (-0.56%)
NFLX   239.19 (-2.45%)
NYSE:EVH

Evolent Health - EVH Stock Forecast, Price & News

$36.39
-0.35 (-0.95%)
(As of 09/29/2022 01:21 PM ET)
Add
Compare
Today's Range
$35.63
$36.57
50-Day Range
$32.98
$39.74
52-Week Range
$21.36
$39.78
Volume
13,932 shs
Average Volume
964,536 shs
Market Capitalization
$3.33 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$49.13

Evolent Health MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
37.1% Upside
$49.13 Price Target
Short Interest
Bearish
7.24% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$3.24 M Sold Last Quarter
Proj. Earnings Growth
266.67%
From $0.06 to $0.22 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.37 out of 5 stars

Computer And Technology Sector

283rd out of 650 stocks

Management Services Industry

5th out of 7 stocks

EVH stock logo

About Evolent Health (NYSE:EVH) Stock

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

Receive EVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter.

EVH Stock News Headlines

Evolent Health to Participate in Upcoming Conferences
Evolent Health: Improving Financials, But There's More
Expert Ratings for Evolent Health
What 6 Analyst Ratings Have To Say About Evolent Health
Why Evolent Health Was Such a Healthy Stock Today
Evolent Health Announces Second Quarter 2022 Results
Evolent Health's Earnings: A Preview
See More Headlines
Receive EVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter.

EVH Company Calendar

Last Earnings
8/02/2022
Today
9/29/2022
Next Earnings (Estimated)
11/02/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Management services
Sub-Industry
N/A
Employees
3,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$49.13
High Stock Price Forecast
$55.00
Low Stock Price Forecast
$40.00
Forecasted Upside/Downside
+35.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

Net Income
$-37,600,000.00
Pretax Margin
-1.72%

Debt

Sales & Book Value

Annual Sales
$907.96 million
Cash Flow
$0.88 per share
Book Value
$7.77 per share

Miscellaneous

Free Float
87,748,000
Market Cap
$3.33 billion
Optionable
Optionable
Beta
1.79

Key Executives

  • Mr. Frank John WilliamsMr. Frank John Williams (Age 56)
    Co-Founder & Chairman
    Comp: $400k
  • Mr. Seth Barrie Blackley (Age 43)
    Co-Founder, CEO & Director
    Comp: $1.74M
  • Mr. John Paul Johnson (Age 38)
    Chief Financial Officer
    Comp: $936.6k
  • Mr. Steve Tutewohl FSAMr. Steve Tutewohl FSA (Age 49)
    MAAA, Chief Operating Officer
    Comp: $1.09M
  • Mr. Aammaad Shams (Age 38)
    Chief Accounting Officer & Controller
    Comp: $341.78k
  • Mr. Jonathan David Weinberg J.D. (Age 54)
    Chief Legal Officer, Gen. Counsel & Sec.
    Comp: $719.1k
  • Mr. Seth R. Frank
    VP of Investor Relations
  • Ms. Jessica Somers
    Sr. VP of Corp. Devel.
  • Dr. Norman C. Payson (Age 73)
    Advisor
  • Dr. John Tam M.D.
    Chief Strategy Officer













EVH Stock - Frequently Asked Questions

Should I buy or sell Evolent Health stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" EVH shares.
View EVH analyst ratings
or view top-rated stocks.

What is Evolent Health's stock price forecast for 2022?

8 analysts have issued 12 month price objectives for Evolent Health's shares. Their EVH share price forecasts range from $40.00 to $55.00. On average, they anticipate the company's share price to reach $49.13 in the next twelve months. This suggests a possible upside of 33.7% from the stock's current price.
View analysts price targets for EVH
or view top-rated stocks among Wall Street analysts.

How have EVH shares performed in 2022?

Evolent Health's stock was trading at $27.67 on January 1st, 2022. Since then, EVH stock has increased by 32.8% and is now trading at $36.74.
View the best growth stocks for 2022 here
.

Are investors shorting Evolent Health?

Evolent Health saw a decrease in short interest in August. As of August 31st, there was short interest totaling 6,400,000 shares, a decrease of 24.3% from the August 15th total of 8,460,000 shares. Based on an average trading volume of 1,110,000 shares, the short-interest ratio is currently 5.8 days.
View Evolent Health's Short Interest
.

When is Evolent Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our EVH earnings forecast
.

How were Evolent Health's earnings last quarter?

Evolent Health, Inc. (NYSE:EVH) posted its quarterly earnings data on Tuesday, August, 2nd. The technology company reported $0.02 EPS for the quarter, topping analysts' consensus estimates of ($0.05) by $0.07. The technology company earned $319.94 million during the quarter, compared to analysts' expectations of $293.31 million. Evolent Health had a positive trailing twelve-month return on equity of 0.41% and a negative net margin of 2.63%.

What guidance has Evolent Health issued on next quarter's earnings?

Evolent Health updated its FY 2022 earnings guidance on Wednesday, August, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.32 billion-$1.36 billion, compared to the consensus revenue estimate of $1.22 billion.

What is Seth Blackley's approval rating as Evolent Health's CEO?

12 employees have rated Evolent Health Chief Executive Officer Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among the company's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Evolent Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET), Chipotle Mexican Grill (CMG), Ford Motor (F), Cisco Systems (CSCO) and Heron Therapeutics (HRTX).

When did Evolent Health IPO?

(EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

How do I buy shares of Evolent Health?

Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Evolent Health's stock price today?

One share of EVH stock can currently be purchased for approximately $36.74.

How much money does Evolent Health make?

Evolent Health (NYSE:EVH) has a market capitalization of $3.37 billion and generates $907.96 million in revenue each year. The technology company earns $-37,600,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis.

How many employees does Evolent Health have?

The company employs 3,500 workers across the globe.

How can I contact Evolent Health?

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The official website for the company is www.evolenthealth.com. The technology company can be reached via phone at (571) 389-6000, via email at investorrelations@evolenthealth.com, or via fax at 571-389-6001.

This page (NYSE:EVH) was last updated on 9/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.